HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Engel, M. E. Articles by Moses, H. L. Search for Related Content PubMed PubMed Citation Articles by Engel, M. E. Articles by Moses, H. L. Social Bookmarking                      What's this?

J Biol Chem, Vol. 273, Issue 16, 9921-9926, April 17, 1998

RhoB Is Stabilized by Transforming Growth Factor  and Antagonizes Transcriptional Activation

From the Department of Cell Biology and the Vanderbilt Cancer Center, Vanderbilt University, Nashville, Tennessee 37232-6838

Transforming growth factor  (TGF-) is the prototype for an evolutionarily conserved superfamily of secreted factors implicated in diverse biological phenomena. The pleiotropic responses to TGF- are initiated by a heteromeric receptor complex that binds and phosphorylates downstream effectors. Among these, the Smads have been extensively studied. However, less attention has been directed toward alternative downstream effectors and their participation in TGF- signal transduction. We show that TGF- promotes accumulation of the labile monomeric GTPase RhoB by antagonizing its normal proteolytic destruction, presumably via the 26 S proteasome. RhoB accumulates in its isoprenylated form. Transient overexpression of wild type RhoB but not its dominant negative mutant RhoB-N19 antagonizes TGF--mediated transcriptional activation. These results suggest a novel mechanism of regulation by TGF- and implicate RhoB as a negative regulator of TGF- signal transduction.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				I. Lajoie-Mazenc, D. Tovar, M. Penary, B. Lortal, S. Allart, C. Favard, M. Brihoum, A. Pradines, and G. Favre MAP1A Light Chain-2 Interacts with GTP-RhoB to Control Epidermal Growth Factor (EGF)-dependent EGF Receptor Signaling J. Biol. Chem., February 15, 2008; 283(7): 4155 - 4164. [Abstract] [Full Text] [PDF]

				L. Boyer, L. Turchi, B. Desnues, A. Doye, G. Ponzio, J.-L. Mege, M. Yamashita, Y. E. Zhang, J. Bertoglio, G. Flatau, et al. CNF1-induced Ubiquitylation and Proteasome Destruction of Activated RhoA Is Impaired in Smurf1-/- Cells Mol. Biol. Cell, June 1, 2006; 17(6): 2489 - 2497. [Abstract] [Full Text] [PDF]

				A. Cordle, J. Koenigsknecht-Talboo, B. Wilkinson, A. Limpert, and G. Landreth Mechanisms of Statin-mediated Inhibition of Small G-protein Function J. Biol. Chem., October 7, 2005; 280(40): 34202 - 34209. [Abstract] [Full Text] [PDF]

				M. Rolli-Derkinderen, V. Sauzeau, L. Boyer, E. Lemichez, C. Baron, D. Henrion, G. Loirand, and P. Pacaud Phosphorylation of Serine 188 Protects RhoA from Ubiquitin/Proteasome-Mediated Degradation in Vascular Smooth Muscle Cells Circ. Res., June 10, 2005; 96(11): 1152 - 1160. [Abstract] [Full Text] [PDF]

				H. Ishida, X. Zhang, K. Erickson, and P. Ray Botulinum Toxin Type A Targets RhoB to Inhibit Lysophosphatidic Acid-Stimulated Actin Reorganization and Acetylcholine Release in Nerve Growth Factor-Treated PC12 Cells J. Pharmacol. Exp. Ther., September 1, 2004; 310(3): 881 - 889. [Abstract] [Full Text] [PDF]

				S. Chauhan, S. Kunz, K. Davis, J. Roberts, G. Martin, M. C. Demetriou, T. C. Sroka, A. E. Cress, and R. L. Miesfeld Androgen Control of Cell Proliferation and Cytoskeletal Reorganization in Human Fibrosarcoma Cells: ROLE OF RhoB SIGNALING J. Biol. Chem., January 9, 2004; 279(2): 937 - 944. [Abstract] [Full Text] [PDF]

				G. M. Wildey, S. Patil, and P. H. Howe Smad3 Potentiates Transforming Growth Factor beta (TGFbeta )-induced Apoptosis and Expression of the BH3-only Protein Bim in WEHI 231 B Lymphocytes J. Biol. Chem., May 9, 2003; 278(20): 18069 - 18077. [Abstract] [Full Text] [PDF]

				A. Masszi, C. Di Ciano, G. Sirokmany, W. T. Arthur, O. D. Rotstein, J. Wang, C. A. G. McCulloch, L. Rosivall, I. Mucsi, and A. Kapus Central role for Rho in TGF-beta 1-induced alpha -smooth muscle actin expression during epithelial-mesenchymal transition Am J Physiol Renal Physiol, May 1, 2003; 284(5): F911 - F924. [Abstract] [Full Text] [PDF]

				K. Stamatakis, E. Cernuda-Morollon, O. Hernandez-Perera, and D. Perez-Sala Isoprenylation of RhoB Is Necessary for Its Degradation. A NOVEL DETERMINANT IN THE COMPLEX REGULATION OF RhoB EXPRESSION BY THE MEVALONATE PATHWAY J. Biol. Chem., December 13, 2002; 277(51): 49389 - 49396. [Abstract] [Full Text] [PDF]

				M. Lerm, M. Pop, G. Fritz, K. Aktories, and G. Schmidt Proteasomal Degradation of Cytotoxic Necrotizing Factor 1-Activated Rac Infect. Immun., August 1, 2002; 70(8): 4053 - 4058. [Abstract] [Full Text] [PDF]

				J. Adnane, C. Muro-Cacho, L. Mathews, S. M. Sebti, and T. Munoz-Antonia Suppression of Rho B Expression in Invasive Carcinoma from Head and Neck Cancer Patients Clin. Cancer Res., July 1, 2002; 8(7): 2225 - 2232. [Abstract] [Full Text] [PDF]

				J. Adnane, E. Seijo, Z. Chen, F. Bizouarn, M. Leal, S. M. Sebti, and T. Munoz-Antonia RhoB, Not RhoA, Represses the Transcription of the Transforming Growth Factor beta Type II Receptor by a Mechanism Involving Activator Protein 1 J. Biol. Chem., March 1, 2002; 277(10): 8500 - 8507. [Abstract] [Full Text] [PDF]

				A.-X. Liu, N. Rane, J.-P. Liu, and G. C. Prendergast RhoB Is Dispensable for Mouse Development, but It Modifies Susceptibility to Tumor Formation as Well as Cell Adhesion and Growth Factor Signaling in Transformed Cells Mol. Cell. Biol., October 15, 2001; 21(20): 6906 - 6912. [Abstract] [Full Text] [PDF]

				W.-Y. Lui, W. M. Lee, and C. Y. Cheng Transforming Growth Factor-{beta}3 Perturbs the Inter-Sertoli Tight Junction Permeability Barrier in Vitro Possibly Mediated via Its Effects on Occludin, Zonula Occludens-1, and Claudin-11 Endocrinology, May 1, 2001; 142(5): 1865 - 1877. [Abstract] [Full Text]

				N. A. Bhowmick, M. Ghiassi, A. Bakin, M. Aakre, C. A. Lundquist, M. E. Engel, C. L. Arteaga, and H. L. Moses Transforming Growth Factor-{beta}1 Mediates Epithelial to Mesenchymal Transdifferentiation through a RhoA-dependent Mechanism Mol. Biol. Cell, January 1, 2001; 12(1): 27 - 36. [Abstract] [Full Text]

				A.-x. Liu, W. Du, J.-P. Liu, T. M. Jessell, and G. C. Prendergast RhoB Alteration Is Necessary for Apoptotic and Antineoplastic Responses to Farnesyltransferase Inhibitors Mol. Cell. Biol., August 15, 2000; 20(16): 6105 - 6113. [Abstract] [Full Text]

				W. Du, P. F. Lebowitz, and G. C. Prendergast Cell Growth Inhibition by Farnesyltransferase Inhibitors Is Mediated by Gain of Geranylgeranylated RhoB Mol. Cell. Biol., March 1, 1999; 19(3): 1831 - 1840. [Abstract] [Full Text] [PDF]

				A Moustakas and C Stournaras Regulation of actin organisation by TGF-beta in H-ras-transformed fibroblasts J. Cell Sci., January 4, 1999; 112(8): 1169 - 1179. [Abstract] [PDF]

				G. Fritz and B. Kaina Ras-related GTPase RhoB Represses NF-kappa B Signaling J. Biol. Chem., January 26, 2001; 276(5): 3115 - 3122. [Abstract] [Full Text] [PDF]

				A.-x. Liu, G. J. Cerniglia, E. J. Bernhard, and G. C. Prendergast RhoB is required to mediate apoptosis in neoplastically transformed cells after DNA damage PNAS, May 22, 2001; 98(11): 6192 - 6197. [Abstract] [Full Text] [PDF]